Reprint
Recent Development of Electrospinning for Drug Delivery
Edited by
March 2020
206 pages
- ISBN978-3-03928-140-4 (Paperback)
- ISBN978-3-03928-141-1 (PDF)
This is a Reprint of the Special Issue Recent Development of Electrospinning for Drug Delivery that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
Several promising techniques have been developed to overcome the poor solubility and/or membrane permeability properties of new drug candidates, including different fiber formation methods. Electrospinning is one of the most commonly used spinning techniques for fiber formation, induced by the high voltage applied to the drug-loaded solution. With modifying the characteristics of the solution and the spinning parameters, the functionality-related properties of the formulated fibers can be finely tuned. The fiber properties (i.e., high specific surface area, porosity, and the possibility of controlling the crystalline–amorphous phase transitions of the loaded drugs) enable the improved rate and extent of solubility, causing a rapid onset of absorption. However, the enhanced molecular mobility of the amorphous drugs embedded into the fibers is also responsible for their physical–chemical instability. This Special Issue will address new developments in the area of electrospun nanofibers for drug delivery and wound healing applications, covering recent advantages and future directions in electrospun fiber formulations and scalability. Moreover, it serves to highlight and capture the contemporary progress in electrospinning techniques, with particular attention to the industrial feasibility of developing pharmaceutical dosage forms. All aspects of small molecule or biologics-loaded fibrous dosage forms, focusing on the processability, structures and functions, and stability issues, are included.
Format
- Paperback
License and Copyright
© 2020 by the authors; CC BY-NC-ND license
Keywords
electrospinning; gentamicin sulfate; polylactide-co-polycaprolactone; drug release kinetics; tissue engineering; growth factor; diabetic; wound healing; nanocomposite; electrospinning; coaxial spinning; core-sheath nanofibers; biomedical; drug delivery; electrospinning; scale-up; processability; biopharmaceuticals; oral dosage form; grinding; aceclofenac; nanofiber; electrospinning; scanning electron microscopy; fourier transform infrared spectroscopy; differential scanning calorimetry; nanotechnology; biotechnology; probiotics; Lactobacillus; Lactococcus; electrospinning; nanofibers; drying; local delivery; viability; antibacterial activity; bacterial bioreporters; drug release; electrospinning; microfibers; nanofibers; UV imaging; wetting; in situ drug release; nanofibers; electrospinning; poorly water-soluble drug; piroxicam; hydroxypropyl methyl cellulose; polydextrose; scanning white light interferometry; nanotechnology; nanofibers; traditional electrospinning; ultrasound-enhanced electrospinning; drug delivery system; haemanthamine; plant-origin alkaloid; electrospinning; amphiphilic nanofibers; self-assembled liposomes; physical solid-state properties; drug release; electrospinning; PCL; gelatin; clove essential oil; antibacterial; biocompatibility; artificial red blood cells; electrospinning and electrospray; pectin; oligochitosan; hydrogel; microcapsules; electrospinning; wound dressings; solvent casting; 3D printing; polymeric carrier; n/a